Log in to search using one of your social media accounts:

 

Why Hormone Replacement Therapy May Be Safer Than You Think

The pendulum has swung from one extreme to the other when it comes to hormone replacement therapy (HRT) to treat symptoms of menopause. At first, the replacement hormones—mostly a combination of estrogen and progestin to replace what the body stops making after menopause—were seen as a panacea. Doctors thought they could not only relieve hot flashes and night sweats, but also prevent chronic aging diseases like heart problems and weakening bones. But studies then found that the supplement hormones could lead to a higher risk of breast cancer—and that they didn’t protect the heart after all. In the latest study on the subject, published in JAMA, researchers led by Dr. JoAnn Manson from the division of preventive medicine at Brigham and Women’s Hospital report on the longest follow-up of the original hormone therapy study, which used data from the Women’s Health Initiative. More than 27,000 women who were randomly assigned to receive either a placebo, a combination of hormones (estrogen plus progestin) or estrogen alone if they had had a hysterectomy. They were followed for 18 years and tracked for chronic diseases like cancer, as well as heart attack and deaths. The women took the hormone therapy for five to seven years. By the end of the 18-year study, the death rates from any cause among the women receiving some form of hormone therapy were similar to that of women who took the placebo. MORE: Hormone Replacement Therapy After Menopause: W...
Source: TIME.com: Top Science and Health Stories - Category: Consumer Health News Authors: Tags: Uncategorized Drugs estrogen Hormone Therapy hormones for menopause hot flashes night sweats progestin Reproductive Health treating menopause Source Type: news

Related Links:

Authors: Tagliabue L, Capozza A, Maioli C, Luciani A, Ierardi AM, Carrafiello G Abstract Since the beginning of second decade of this century, when it was introduced in many oncologic scenarios, immunotherapy has become an important tool in the management of a growing number of cancers. Engaging the host immune system in cancer therapy seems to be useful, improving not only progression free survival but also overall survival, until the achieving the goal that many advanced cancers, previously considered without effective treatment options, have now become successfully treatable. Moreover, considering the relatively...
Source: Quarterly Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Tags: Q J Nucl Med Mol Imaging Source Type: research
(Reuters Health) – The public’s exposure to arsenic, a naturally occurring chemical element linked to cancer and birth defects, declined after U.S. regulators tightened restrictions on the amount of arsenic allowed in drinking water, a recent study suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Abstract Patient classification through feature selection (FS) based on gene expression data (GED) has already become popular to the research communities. T-test is the well-known statistical FS method in GED analysis. However, it produces higher false positives and lower accuracies for small sample sizes or in presence of outliers. To get rid from the shortcomings of t-test with small sample sizes, SAM has been applied in GED. But, it is highly sensitive to outliers. Recently, robust SAM using the minimum β-divergence estimators has overcome all the problems of classical t-test &SAM and it has been succe...
Source: Bioinformation - Category: Bioinformatics Authors: Tags: Bioinformation Source Type: research
Authors: Abdel-Rahman O Abstract BACKGROUND: The current study tried to evaluate the factors affecting 10- to 20- years' survival among long term survivors (>5 years) of colorectal cancer (CRC) and to examine if risk of death from CRC beyond five years varies based on baseline characteristics. PATIENTS AND METHODS: Surveillance, Epidemiology and End Results (SEER) database (1988-2008) was queried through SEER*Stat program. Univariate probability of overall and cancer-specific survival was determined by the life tables' option of the SPSS and the difference between groups was examined through Wilcoxon (Gehan)...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
Authors: Nagasaka M, Gadgeel SM Abstract INTRODUCTION: Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have tumors ≥ 4 cm. The survival advantage is modest with approximately 5% at 5 years. Areas covered: This review article presents relevant data regarding chemotherapy use in the perioperative setting for early stage NSCLC. A literature search was performed utilizing PubMed as well as clinical trial.gov. Randomized phase III studies in this setting including adjuvant...
Source: Expert Review of Anticancer Therapy - Category: Cancer & Oncology Tags: Expert Rev Anticancer Ther Source Type: research
In conclusion, we demonstrated that METTL3 was frequently up‐regulated in human HCC and contributed to HCC progression. METTL3 repressed SOCS2 expression in HCC via the m6A‐YTHDF2 dependent mechanism. Thus, our findings suggested a new dimension of epigenetic alteration in liver carcinogenesis. This article is protected by copyright. All rights reserved.
Source: Hepatology - Category: Internal Medicine Authors: Tags: Hepatobiliary Malignancies Source Type: research
SOLE shows that after 5 years of adjuvant therapy, intermittent dosing with letrozole was similar to continuous dosing, suggesting that a'drug holiday'is safe.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Health blogger Olivia Budgen, from Brisbane, Australia, made an Instagram post to 'challenge' people's beliefs about cancer, arguing that it isn't 'actually bad at all'.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Authors: Cho JH PMID: 29168410 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
CONCLUSIONS: The finding of a dMMR CRC had consequences for decisions on chemotherapy in a relative high proportion of patients. We recommend testing in all patients with CRC independent of age at diagnosis, as proper treatment decisions and genetic counselling are very important. PMID: 29161904 [PubMed - as supplied by publisher]
Source: Scandinavian Journal of Gastroenterology - Category: Gastroenterology Tags: Scand J Gastroenterol Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer of the Uterus | Cardiology | Endometrial Cancer | Health | Heart | Heart Attack | Heart Disease | Hormonal Therapy | Hormone Replacement Therapy | Hormones | Hospitals | Hysterectomy | Men | Menopause | Orthopaedics | Osteoporosis | Science | Study | USA Health | Women